SGLT2 Inhibitors Linked to Breast Cancer Outcomes
In a groundbreaking systematic review and meta-analysis recently published in BMC Cancer, researchers have shed new light on the complex relationship between sodium-glucose cotransporter-2 inhibitors...
















